Sigrid Therapeutics Patents

Patent portfolio assigned to Sigrid Therapeutics (verified via public assignee records). Estimated patent count: 10. Stockholm biotech (founded 2014); patented SiPore/SiPore21 mesoporous silica oral medical device for blood-sugar control. Own site states 'patented SiPore technology' and '10+ patents' -> has_patents=true, estimate ~10. No named customers or named direct competitors found on fetched sources.